Weiquan Gu
Overview
Explore the profile of Weiquan Gu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nie Y, Feng F, Luo W, Sanders A, Zhang Y, Liang J, et al.
Cancer Gene Ther
. 2023 Oct;
30(11):1583.
PMID: 37833404
No abstract available.
2.
Gu W, Zhang H, Lu Y, Li M, Yang S, Liang J, et al.
Cancer Res Treat
. 2023 Feb;
55(3):841-850.
PMID: 36791768
Purpose: We aimed to evaluate whether the addition of pemetrexed is effective in improving progression-free survival (PFS) in epidermal growth factor receptor (EGFR)-mutated patients with or without concomitant alterations. Materials...
3.
Nie Y, Feng F, Luo W, Sanders A, Zhang Y, Liang J, et al.
Cancer Gene Ther
. 2022 Mar;
29(10):1405-1417.
PMID: 35354949
The specific biological function of transient receptor potential vanilloid 1 (TRPV1) in pathogenesis of lung adenocarcinoma (LUAD) remains unclear. In this study, TRPV1 expression in tumor tissues, primary cells and...
4.
Cai L, Wang W, Wang F, Zhang R, Zhang L, Qi H, et al.
Transl Cancer Res
. 2022 Feb;
8(7):2564-2569.
PMID: 35117013
Background: Targeted therapy has been proven to be effective in lung cancer patients with specific driver gene mutations. At present, Sanger sequencing is still the gold standard in clinical practice...
5.
Gu W, Yang J, Wang Y, Xu J, Wang X, Du F, et al.
Am J Cancer Res
. 2021 Sep;
11(8):3893-3906.
PMID: 34522456
Deregulation of fibroblast growth factor receptor (FGFR) network is common in cancer due to activating mutations, gene amplifications and chromosomal translocations. Currently, various FGFR inhibitors are being developed. In order...
6.
Gu W, Wang N, Gu W, Qiu Y, Zhang H, Liang J, et al.
Transl Lung Cancer Res
. 2020 Jul;
9(3):629-638.
PMID: 32676325
Background: The difference in molecular gene mutation profile, tumor mutational burden (TMB) and their prognostic effects in lung adenocarcinoma between different ethnic groups are still unknown. A retrospective analysis was...
7.
Zhu L, Jiang L, Yang J, Gu W, He J
J Thorac Dis
. 2018 Jun;
10(4):2397-2402.
PMID: 29850145
Background: Adenosquamous carcinoma (ASC) is a mixed glandular and squamous cell carcinoma (SCC) with more aggressive behavior than the other histologic subtypes of lung cancer. We aim to evaluate the...
8.
Yang S, Yang J, Gu W, Ye J, Zhu L, Wang F, et al.
Nan Fang Yi Ke Da Xue Xue Bao
. 2014 Sep;
34(8):1210-1.
PMID: 25176099
Objective: To assess the clinical value of single-port video-assisted thoracoscopic surgery (VATS) for treatment of pulmonary diseases. Methods: From October, 2009 to December, 2013, 105 patients with pulmonary diseases were...
9.
Wang X, Zhong N, Lu S, Liu C, Gu W
Neuroreport
. 2009 Dec;
21(2):123-6.
PMID: 19997039
We investigated the effects of rule learning based on information granularity. Using two homogeneous Boolean arithmetic tasks, we examined parietal cortex activity during the calculation of labile and stabilized learning....